Skip to content

Clinical efficacy of acupuncture combined with Western medicine in the treatment of mild to moderate Alzheimer's disease: A protocol of a randomized controlled trial

Clinical efficacy of acupuncture combined with Western medicine in the treatment of mild to moderate Alzheimer's disease: A protocol of a randomized controlled trial

Status
Unknown
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20220817004
Enrollment
78
Registered
2022-08-17
Start date
2022-09-06
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acupuncture and Moxibustion are traditional treatments in China and are widely used in clinical practice. In the treatment of AD, it has the characteristics of multiple levels, multiple pathways, and multiple targets, and the advantages of reliable efficacy and few side effects[7, 8]. Recent systematic reviews have shown [9, 10] that acupuncture combined with Western medicine is superior to Western medicine alone in improving cognitive function and activities of daily living in AD patients. At t

Interventions

Patients will receive oral donepezil hydrochloride 5 mg at bedtime (Weicai Pharmaceutical Co., Ltd., China, GYZZ H20050978, 5 mg/tablet) once a day for 24 weeks. Acupuncture treatment: Baihui (GV20),
Experimental Other,Experimental Other
acupuncture combined with donepezil hydrochloride orally,sham acupuncture combined with donepezil hydrochloride orally

Sponsors

Rong Guo
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1)There are other diseases that may lead to dementia besides Alzheimer 's disease; (2) Acute cardiovascular and cerebrovascular events (such as unstable angina pectoris, myocardial infarction, stroke, etc.) occurred within 3 months before screening; (3) There was skin ulceration at acupuncture points; (4) Refusal or fear of acupuncture; (5) Those who have participated in or are participating in other clinical trials within the past 1 month;

Exclusion criteria

Exclusion criteria: (1) There are other diseases that may lead to dementia besides Alzheimer 's disease; (2) Acute cardiovascular and cerebrovascular events (such as unstable angina pectoris, myocardial infarction, stroke, etc.) occurred within 3 months before screening; (3) There was skin ulceration at acupuncture points; (4) Refusal or fear of acupuncture; (5) Those who have participated in or are participating in other clinical trials within the past 1 month;

Design outcomes

Primary

MeasureTime frame
Mini-mental state examination (MMSE) 24 weeks including five items: orientation; memory; attention and calculation, memory and language ability.

Secondary

MeasureTime frame
Activities of daily living (ADL) 24 weeks including 6 aspects related to physical self-care and 8 aspects related to the ability to use tools.

Countries

China

Contacts

Public ContactKangmei Zhou

Deyang Vocational College of Technology and Trade, Deyang 618300, Sichuan province, China.

hejierong1688@126.com15681015509

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026